Global Nanoparticles Market in Biotechnology and Pharmaceutical Sectors – Drivers, Trends, and Forecasts | Technavio

LONDON–()–The global nanoparticles
market in biotechnology and pharmaceutical sectors
is expected to
grow at a CAGR of close to 22% during the period 2017-2021, according to
a new market research study by Technavio.

The report categorizes the global nanoparticles market in biotechnology
and pharmaceutical sectors by end-user that include biotechnology and
pharmaceutical. The report also determines the geographic breakdown of
the market in terms of detailed analysis and impact, which includes key
geographies such as APAC, the Americas, and EMEA.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2
Technavio reports and get the third for free.

Market driver: increasing focus on nanotechnology research

Nanotechnology is the field of studying particles that are in the size
range of one to 100 nm. Physicists ascertain that atoms and molecules of
the smallest size can be manipulated and controlled to provide
breakthroughs in multiple fields such as biology, chemistry, physics,
material science, and engineering. Nanotechnology has improved novel
research applications and materials that have benefited multiple areas
of research, thereby creating opportunities for market growth.

According to Tasneem Ali, a lead analyst at Technavio for lab
equipment
research, “Nanotechnology has two divisions that
include nanodevices and nanoparticles.
Nanoparticles
have widespread application than nanodevices. They are used in
pharmaceuticals for drug delivery and drug discovery and in
biotechnology for studying cellular dynamics and stem cell
research. Additionally, with investments by government and technology
firms in the development of nanotechnology, the market is expected to
grow in the coming years. The US is one of the largest investors in
nanotechnology.”

Looking for more information on this market? Request
a free sample report

Technavio’s sample reports are free of charge and contain multiple
sections of the report including the market size and forecast, drivers,
challenges, trends, and more.

Market trend: increasing demand for nanoparticles in stem cell therapy

Stem cells have the potential of developing into different cell types in
the body during early life and growth. Stem cells function as an
internal repair system that divides to replenish other cells for as long
as the animal or the person lives. Stem cells include embryonic stem
cells and non-embryonic adult stem cells that are unspecialized cells.
Advancements in stem cell research depict the tremendous potential of
stem cells that can change the perception of diseases. Over the past 50
years, several effective stem cell therapies have been developed, which
is expected to continue during the forecast period. For instance, in
1956, the first successful bone marrow-derived stem cell transplant was
performed on a leukemia patient by Dr. Donnall Thomas in New York.

Market challenge: challenges in development of nanoparticles for
therapeutics

Although nanoparticle-based therapeutics overcome biological barriers by
effectively delivering hydrophobic drugs at preferentially target sites
of disease, only a small number of nanoparticle-based medicines have
been approved for clinical use. Manufacturers of nanoparticles face
several challenges and hurdles at different stages of product
development. The complexity of nanoparticles requires careful design and
engineering for their three-dimensional construction. Their development
requires detailed analysis of orthogonal methods, pharmacological
profiles, and biological behaviors.

Is your business on track for a successful future? Learn
how Technavio can help

Technavio helps businesses anticipate changes in their marketplace,
make proactive adjustments, and develop effective strategies to optimize
their market positions.

Key vendors in the market:

  • Merck
  • F. Hoffmann-La Roche
  • GE Healthcare
  • Novartis

The global nanoparticles
market in biotechnology and pharmaceutical sectors
is characterized
by the presence of diverse regional and international vendors. The
regional vendors face stiff competition from the international players
in terms of quality, price, market reach, and financial resources. The
competition will further increase with the increase in product
innovations, product and service extensions, and M&A. International
players are predicted to grow by acquiring regional or local players.

Get a sample copy of the global
nanoparticles market in biotechnology and pharmaceutical sectors
report
free of cost

Access Technavio’s continuously growing lab
equipment
research library and find expert analysis on hundreds
of markets.

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.